title: [Predictifs factors of the algodystrophy evolution in a rheumatology department among 60 cases].
abstract: We analysed 60 cases of algodystrophy admitted in the rheumatology department of the university hospital of Monastir. We used a univariate analysis to search the factors associated with the disease evolution. Our patients were 40 males and 20 females. The mean age was 51.6 ans (16 - 81). The traumatisme was the dominant cause (46.7% of the cases). Calcitonines were used in 70% of the cases. Functional results at one year were satisfying and not satisfying in 62.5% and 37.5% of the cases, respectively. The primitive algodystrophy was associated with a satisfying result. Sequella were observed in 10.5% of the cases. The primitive algodystrophy was associated with a satisfying result. Algodystrophy remain a benign disease and the best treatment remains the preventive one mainly in traumatic and orthopaedic circumstances.
authors.affiliation: Servide de Rhumatologie, EPS Monastir.
authors.forename: Ismail
authors.initials: I
authors.lastname: Bejia
authors.forename: Anis
authors.initials: A
authors.lastname: Ben Khalifa
authors.forename: Zohra
authors.initials: Z
authors.lastname: Ben Salah
authors.forename: Samia
authors.initials: S
authors.lastname: Bejaoui
authors.forename: Mongi
authors.initials: M
authors.lastname: Touzi
authors.forename: Naceur
authors.initials: N
authors.lastname: Bergaoui
mesh_terms: D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D012019:Reflex Sympathetic Dystrophy / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000929:Antidepressive Agents, Tricyclic; D004164:Diphosphonates; D002116:Calcitonin